跳至主要内容
临床试验/ACTRN12616000442404
ACTRN12616000442404尚未招募未知

To evaluate whether number and intracellular protein content of stem/progenitor cells (SPCs) in diabetic patients with lower extremity neuropathic wounds (diabetic foot ulcer or DFU) are correlated with wound healing and with diabetes-related factors.

ational Institutes of Health (NIH),0 个研究点目标入组 800 人开始时间: 2016年4月6日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
21 Years 至 90 Years(—)
性别
All

入选标准

  • Individuals who are 21 to 90, type 1 or type 2 diabetic patients with a neuropathic DFU Wagner grade 1 to 4 will be the study population. If a patient has more than one lower extremity ulcer, the one that would take the longest to heal in the opinion of the patient’s primary physician will be the target ulcer for study. To differentiate the neuropathic ulcer population from those patients with inadequate arterial blood flow (neuroischemic ulcers) all patients considered for the investigation will have skin perfusion pressure > 25 mmHg OR an ankle/brachial index of > 0.65 (if calcified vessels are suspected use the toe/brachial index). There is no predetermined wound care requirement prior to enrolment, and wound care as per best care will be provided in return for participation in the trial

排除标准

  • You are under the age of 21 years old or over 90 years
  • You do not have diabetes
  • You do not have a neuropathic foot ulcer related to diabetes
  • You have a history of a seizure disorder
  • You are pregnant
  • Severe asthma
  • COPD (Chronic Obstructive Pulmonary Disease)
  • Spontaneous pneumothorax (ruptured lung)

研究者

发起方
ational Institutes of Health (NIH),

相似试验